Anatara Lifesciences (ANR) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock ANR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Anatara Lifesciences Addresses ASX Query Amid Market ActivitySeptember 4, 2025 | tipranks.comAnatara Lifesciences Reports Increased Loss Amidst Continued OperationsAugust 13, 2025 | tipranks.comAnatara Lifesciences Converts Performance Rights to SharesAugust 3, 2025 | tipranks.comAnatara Lifesciences Secures R&D Tax Incentive to Propel Anti-Obesity ResearchJuly 27, 2025 | tipranks.comAnatara Lifesciences Sees Change in Substantial Shareholder InterestsJuly 1, 2025 | tipranks.comAnatara Lifesciences Secures Hong Kong Patent for GaRP ProductMay 18, 2025 | tipranks.comAnatara Lifesciences Reports GaRP-IBS Trial Results and Future DirectionsApril 16, 2025 | tipranks.comAnatara Lifesciences Advances GaRP-IBS Trial and Anti-Obesity ProjectMarch 9, 2025 | tipranks.comAnatara Lifesciences Initiates Trading Halt Ahead of Key IBS Trial UpdateMarch 5, 2025 | tipranks.comAnatara Lifesciences Reports Revenue Surge Amid Rising LossesFebruary 24, 2025 | tipranks.comAnatara Lifesciences Secures Australian Patent for GaRP, Fortifying Market PositionJanuary 27, 2025 | tipranks.comAnatara Lifesciences Advances GaRP-IBS Trial and Expands PortfolioJanuary 14, 2025 | tipranks.comAnatara Lifesciences Issues New Unlisted OptionsDecember 23, 2024 | tipranks.comAnatara Lifesciences Director Increases ShareholdingDecember 23, 2024 | tipranks.comAnatara Lifesciences Updates Investors on Health Product ProgressDecember 22, 2024 | tipranks.comAnatara Lifesciences Secures Funding for Key ProjectsDecember 19, 2024 | tipranks.comAnatara Lifesciences Advances GaRP-IBS Clinical TrialDecember 3, 2024 | tipranks.comAnatara Lifesciences Emphasizes Cautious Investment ApproachDecember 1, 2024 | tipranks.comAnatara Lifesciences Hosts Webinar on New InitiativesDecember 1, 2024 | tipranks.comAnatara Lifesciences Unveils Share Purchase PlanNovember 26, 2024 | tipranks.comEdwards LifesciencesJanuary 23, 2024 | forbes.comEris Lifesciences Ltd.October 5, 2023 | wsj.comEdwards Lifesciences (EW) Q2 Earnings Top Estimates, View UpAugust 9, 2023 | finance.yahoo.comMega Lifesciences PCLJune 16, 2023 | wsj.comZydus Lifesciences Ltd.May 10, 2023 | wsj.comInnovation begins with collaboration: Steven LydeamoreApril 4, 2023 | proactiveinvestors.com.auAnatara Lifesciences Ltd (ANR.AX)March 29, 2023 | finance.yahoo.comEdwards Lifesciences Stock (NYSE:EW), DividendsMarch 11, 2023 | benzinga.comAnatara Lifesciences LtdSeptember 21, 2022 | reuters.comAnatara Lifesciences Ltd (ANR)September 7, 2021 | investing.comAnatara Lifesciences Limited (ANR.AX) Meet the CEO Investor WebinarSeptember 6, 2021 | sg.finance.yahoo.comAnatara Lifesciences Limited (ANR.AX) Investor PresentationSeptember 6, 2021 | uk.finance.yahoo.comAnatara Lifesciences Limited (ANR.AX) Launches IBS-D Clinical Trial Recruitment WebsiteAugust 20, 2021 | au.finance.yahoo.comAnatara Lifesciences Limited (ANR.AX) Successful Piglet StudyAugust 6, 2021 | au.finance.yahoo.comAnatara Lifesciences Limited (ANR.AX) Monthly Activities ReportJuly 28, 2021 | uk.finance.yahoo.com Get Anatara Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ANR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ANR Media Mentions By Week ANR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANR News Sentiment▼0.000.92▲Average Medical News Sentiment ANR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANR Articles This Week▼00▲ANR Articles Average Week Get the Latest News and Ratings for ANR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Anatara Lifesciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SBTX News MBX News SAR News POLB News AREC News FUM News GSD News HEM News IBIO News FAB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:ANR) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anatara Lifesciences Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Anatara Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.